Systematic identification of genomic markers of drug sensitivity in cancer cells
Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hu...
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| 格式: | Journal article |
| 語言: | English |
| 出版: |
Springer Nature
2012
|
| _version_ | 1826258844474408960 |
|---|---|
| author | Garnett, MJ Edelman, EJ Heidorn, SJ Greenman, CD Dastur, A Lau, KW Greninger, P Thompson, IR Luo, X Soares, J Liu, Q Iorio, F Surdez, D Chen, L Milano, RJ Bignell, GR Tam, AT Davies, H Stevenson, JA Barthorpe, S Lutz, SR Lawrence, K Haber, DA McLaren-Douglas, A Mitropoulos, X Mironenko, T Thi, H Richardson, L Zhou, W Jewitt, F Zhang, T O'Brien, P Boisvert, JL Price, S Hur, W Yang, W Deng, X Butler, A Choi, HG Chang, JW Baselga, J Stamenkovic, I Engelman, JA Sharma, SV Delattre, O Saez-Rodriguez, J Gray, NS Settleman, J Futreal, PA Ramaswamy, S Stratton, MR McDermott, U Benes, CH |
| author_facet | Garnett, MJ Edelman, EJ Heidorn, SJ Greenman, CD Dastur, A Lau, KW Greninger, P Thompson, IR Luo, X Soares, J Liu, Q Iorio, F Surdez, D Chen, L Milano, RJ Bignell, GR Tam, AT Davies, H Stevenson, JA Barthorpe, S Lutz, SR Lawrence, K Haber, DA McLaren-Douglas, A Mitropoulos, X Mironenko, T Thi, H Richardson, L Zhou, W Jewitt, F Zhang, T O'Brien, P Boisvert, JL Price, S Hur, W Yang, W Deng, X Butler, A Choi, HG Chang, JW Baselga, J Stamenkovic, I Engelman, JA Sharma, SV Delattre, O Saez-Rodriguez, J Gray, NS Settleman, J Futreal, PA Ramaswamy, S Stratton, MR McDermott, U Benes, CH |
| author_sort | Garnett, MJ |
| collection | OXFORD |
| description | Clinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines—which represent much of the tissue-type and genetic diversity of human cancers—with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing’s sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies. |
| first_indexed | 2024-03-06T18:40:25Z |
| format | Journal article |
| id | oxford-uuid:0cacd2c4-646a-47a2-b6d7-ada26880b1d8 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T18:40:25Z |
| publishDate | 2012 |
| publisher | Springer Nature |
| record_format | dspace |
| spelling | oxford-uuid:0cacd2c4-646a-47a2-b6d7-ada26880b1d82022-03-26T09:36:23ZSystematic identification of genomic markers of drug sensitivity in cancer cellsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:0cacd2c4-646a-47a2-b6d7-ada26880b1d8EnglishSymplectic ElementsSpringer Nature2012Garnett, MJEdelman, EJHeidorn, SJGreenman, CDDastur, ALau, KWGreninger, PThompson, IRLuo, XSoares, JLiu, QIorio, FSurdez, DChen, LMilano, RJBignell, GRTam, ATDavies, HStevenson, JABarthorpe, SLutz, SRLawrence, KHaber, DAMcLaren-Douglas, AMitropoulos, XMironenko, TThi, HRichardson, LZhou, WJewitt, FZhang, TO'Brien, PBoisvert, JLPrice, SHur, WYang, WDeng, XButler, AChoi, HGChang, JWBaselga, JStamenkovic, IEngelman, JASharma, SVDelattre, OSaez-Rodriguez, JGray, NSSettleman, JFutreal, PARamaswamy, SStratton, MRMcDermott, UBenes, CHClinical responses to anticancer therapies are often restricted to a subset of patients. In some cases, mutated cancer genes are potent biomarkers for responses to targeted agents. Here, to uncover new biomarkers of sensitivity and resistance to cancer therapeutics, we screened a panel of several hundred cancer cell lines—which represent much of the tissue-type and genetic diversity of human cancers—with 130 drugs under clinical and preclinical investigation. In aggregate, we found that mutated cancer genes were associated with cellular response to most currently available cancer drugs. Classic oncogene addiction paradigms were modified by additional tissue-specific or expression biomarkers, and some frequently mutated genes were associated with sensitivity to a broad range of therapeutic agents. Unexpected relationships were revealed, including the marked sensitivity of Ewing’s sarcoma cells harbouring the EWS (also known as EWSR1)-FLI1 gene translocation to poly(ADP-ribose) polymerase (PARP) inhibitors. By linking drug activity to the functional complexity of cancer genomes, systematic pharmacogenomic profiling in cancer cell lines provides a powerful biomarker discovery platform to guide rational cancer therapeutic strategies. |
| spellingShingle | Garnett, MJ Edelman, EJ Heidorn, SJ Greenman, CD Dastur, A Lau, KW Greninger, P Thompson, IR Luo, X Soares, J Liu, Q Iorio, F Surdez, D Chen, L Milano, RJ Bignell, GR Tam, AT Davies, H Stevenson, JA Barthorpe, S Lutz, SR Lawrence, K Haber, DA McLaren-Douglas, A Mitropoulos, X Mironenko, T Thi, H Richardson, L Zhou, W Jewitt, F Zhang, T O'Brien, P Boisvert, JL Price, S Hur, W Yang, W Deng, X Butler, A Choi, HG Chang, JW Baselga, J Stamenkovic, I Engelman, JA Sharma, SV Delattre, O Saez-Rodriguez, J Gray, NS Settleman, J Futreal, PA Ramaswamy, S Stratton, MR McDermott, U Benes, CH Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title | Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title_full | Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title_fullStr | Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title_full_unstemmed | Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title_short | Systematic identification of genomic markers of drug sensitivity in cancer cells |
| title_sort | systematic identification of genomic markers of drug sensitivity in cancer cells |
| work_keys_str_mv | AT garnettmj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT edelmanej systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT heidornsj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT greenmancd systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT dastura systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT laukw systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT greningerp systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT thompsonir systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT luox systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT soaresj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT liuq systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT ioriof systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT surdezd systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT chenl systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT milanorj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT bignellgr systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT tamat systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT daviesh systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT stevensonja systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT barthorpes systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT lutzsr systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT lawrencek systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT haberda systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT mclarendouglasa systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT mitropoulosx systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT mironenkot systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT thih systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT richardsonl systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT zhouw systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT jewittf systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT zhangt systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT obrienp systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT boisvertjl systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT prices systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT hurw systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT yangw systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT dengx systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT butlera systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT choihg systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT changjw systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT baselgaj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT stamenkovici systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT engelmanja systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT sharmasv systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT delattreo systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT saezrodriguezj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT grayns systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT settlemanj systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT futrealpa systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT ramaswamys systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT strattonmr systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT mcdermottu systematicidentificationofgenomicmarkersofdrugsensitivityincancercells AT benesch systematicidentificationofgenomicmarkersofdrugsensitivityincancercells |